More on BBOT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:BBOT)
Delayed: 8.82 +0.02 (0.23%)
Prev. Close $8.80  
Open$8.70 
52 Wk High$ 
52 Wk Low$ 
Day High$8.90 
Day Low$8.54 
P/E N/A  
EPS$ 
Volume145,597 

Friends, Peers and Foes (?): ERAS RVMD (more...)

Sep 1, 2026 04:05 PM BBOT to Participate in Upcoming Investor Healthcare Conferences
Aug 14, 2026 09:10 AM BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $25 at JPMorgan
Aug 11, 2026 05:03 PM BridgeBio Oncology Therapeutics, Inc. (BBOT) Misses Q2 EPS by 70468c
Aug 11, 2026 04:40 PM BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Aug 11, 2026 04:05 PM BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
Jul 8, 2026 03:12 AM JPMorgan Starts BridgeBio Oncology Therapeutics, In (BBOT) at Overweight
Jul 6, 2026 06:00 PM Form 4 BridgeBio Oncology Thera For: Jul 01 Filed by: Cobo Marc
Jul 6, 2026 06:00 PM Form 4 BridgeBio Oncology Thera For: Jul 01 Filed by: Elmelech Idan
Jul 6, 2026 06:00 PM Form 4 BridgeBio Oncology Thera For: Jul 01 Filed by: Beltran Pedro
Jul 6, 2026 06:00 PM Form 4 BridgeBio Oncology Thera For: Jul 01 Filed by: Ben Yong
View All Articles

Entities mentioned with BBOT

View All Entities